Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration

IMPORTANCE: Emerging policies drafted by the pharmaceutical industry indicate that they will transparently share clinical trial data. These data offer an unparalleled opportunity to advance evidence-based medicine and support decision-making. OBJECTIVE: To evaluate the eligibility of independent, qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Natansh D., Abuhelwa, Ahmad Y., McKinnon, Ross A., Boddy, Alan V., Haseloff, Mark, Wiese, Michael D., Hoffmann, Tammy C., Perakslis, Eric D., Rowland, Andrew, Sorich, Michael J., Hopkins, Ashley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335250/
https://www.ncbi.nlm.nih.gov/pubmed/35900732
http://dx.doi.org/10.1001/jamaoncol.2022.2867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335250/
https://www.ncbi.nlm.nih.gov/pubmed/35900732
http://dx.doi.org/10.1001/jamaoncol.2022.2867

Ejemplares similares